Glycemic alert in good health WE SHOULD BE CONSCIOUS OF OUR GLYCEMIC STATE WHEN WE ARE IN GOOD HEALTH As people age, the risk of developing diabetes increases, with approximately 25% of adults aged 65 years or older having diabetes. Diabetes is a chronic condition that affects the way the body processes blood sugar (glucose)….
Stevia the sugar alternative This sugar substitute has gained popularity in recent years as a zero-calorie sugar substitute that is sweeter than sugar and has a low glycemic index, meaning it doesn’t raise blood sugar levels as quickly as sugar does. Sugar substitute is also safe for consumption and doesn’t have any adverse effects on…
Longevity of Diabetes is related to Low carb plant diet New Research A new study suggests taking low carb plant origin diet for longevity and healthy The approach will keep you fit .To improve your diet and reduce the risk of worsening diabetes, consider incorporating more whole grains, such as brown rice, quinoa, and whole…
78% Price cut by Sanof Pharma: A Milestone for Diabetes Patients Major Price cut by Sanofi to Address Diabetes Care Sanofi Pharma, one of the largest global pharmaceutical companies, has announced a groundbreaking 78% reduction in insulin costs. This move aims to address the financial strain on diabetes patients, making lifesaving medication more accessible to…
Diabetic Nephropathy: A Comprehensive Guide to Understanding, Prevention, and Management Diabetic nephropathy, a severe complication of diabetes, is the leading cause of end-stage kidney disease (ESKD) worldwide. Approximately 30–40% of individuals with diabetes develop this condition, underscoring its significant public health impact. Characterized by progressive kidney damage due to prolonged hyperglycemia. Diabetic nephropathy silently impairs…
75% Insulin price Cut by Novo Nordisk for insulin products in response to Public Pressure The announcement for substantial insulin price cut by Novo Nordisk n the list prices of several of its insulin products, with cuts of up to 75% set to take effect from January 2024. This move comes as part of the…
Breaking New Ground: Exenatide, a GLP-1 Receptor Agonist, Emerges as a Promising Therapy for Idiopathic Intracranial Hypertension Idiopathic intracranial hypertension (IIH), a rare neurological disorder marked by elevated intracranial pressure (ICP) of unknown origin, disproportionately affects young women with obesity. Its hallmark symptoms—blinding headaches, vision loss, tinnitus, and cognitive impairment—significantly impair quality of life. With…
Autoimmune Disorder Breakthrough: PEP Shows Promise to treat Multiple sclerosis, rheumatoid arthritis and more Another significant breakthrough has emerged in the fight against autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. Researchers have identified a chemical compound, phosphoenolpyruvate (PEP), that shows promise as a new treatment option for autoimmune disorder. Understanding Autoimmune Disorder: Autoimmune…
Insomniac affects heart health in diabetes The Relationship Between insomniac and Heart Health in Diabetic Patients: Insights from Large-Scale Studies Recent research highlights a critical relationship between insomniac and heart health, particularly in diabetic patients. One of the key findings is that insomniac is at risk of elevated levels of cortisol, a stress hormone that…
